AR039651A1 - Derivados de isoquinolina - Google Patents
Derivados de isoquinolinaInfo
- Publication number
- AR039651A1 AR039651A1 ARP030101412A ARP030101412A AR039651A1 AR 039651 A1 AR039651 A1 AR 039651A1 AR P030101412 A ARP030101412 A AR P030101412A AR P030101412 A ARP030101412 A AR P030101412A AR 039651 A1 AR039651 A1 AR 039651A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- coor8
- halogen
- isoquinoline derivatives
- nr6r7
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
Abstract
Derivados de isoquinolina, medicamentos que contienen estos compuestos, un proceso para su preparación así como su uso para la preparación de medicamentos para el tratamiento o prevención de enfermedades en que los inhibidores de la MAO-B puedan ser beneficiosos. Reivindicación 1: Compuestos de la fórmula general (1) en donde Y es >C=O o -CH2-, Z es >C=O o -CH2-, R1 es H, o es un grupo de fórmula (2) en donde R3 es -(CH2)n-CO-NR6R7; -(CH2)n-COOR8; -CHR9-COOR8, -(CH2)n-CN; -(CH2)p-OR8, -(CH2)n-NR6R7, -(CH2)n-CF3; -(CH2)n-NH-COR9, -(CH2)n-NH-COOR8; -(CH2)n-tetrahidrofuranilo; -(CH2)p-SR8; -(CH2)p-SO-R9; o -(CH2)n-CS-NR5R6; R4 es H, C1-6 alquilo, -(CH2)p-OR8, -(CH2)p-SR8, o bencilo; R5 es H, C1-6 alquilo, -(CH2)p-OR8, -(CH2)p-SR8, o bencilo; R6 y R7 son independientemente el uno del otro H, o C1-6 alquilo; R8 es H o C1-6 alquilo; R9 es C1-6 alquilo; m es 1, 2 o 3; n es 0, 1, o 2; y p es 1 o 2; R2 es independientemente seleccionado de halógeno, halógeno- (C1-6)-alquilo, ciano, C1-6-alcoxilo o halógeno-(C1-6)-alcoxilo; así como sus sales farmacéuticamente aceptables.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02009253 | 2002-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR039651A1 true AR039651A1 (es) | 2005-03-02 |
Family
ID=29265896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030101412A AR039651A1 (es) | 2002-04-26 | 2003-04-24 | Derivados de isoquinolina |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6818774B2 (es) |
| EP (1) | EP1501804B1 (es) |
| JP (1) | JP4322685B2 (es) |
| KR (1) | KR100681585B1 (es) |
| CN (1) | CN1310890C (es) |
| AR (1) | AR039651A1 (es) |
| AT (1) | ATE440821T1 (es) |
| AU (1) | AU2003227614B2 (es) |
| BR (1) | BR0309562A (es) |
| CA (1) | CA2483461C (es) |
| DE (1) | DE60328978D1 (es) |
| DK (1) | DK1501804T3 (es) |
| ES (1) | ES2329354T3 (es) |
| GT (1) | GT200300095A (es) |
| HK (1) | HK1080836A1 (es) |
| HR (1) | HRP20040952A2 (es) |
| IL (1) | IL164677A0 (es) |
| MX (1) | MXPA04010537A (es) |
| MY (1) | MY133527A (es) |
| NO (1) | NO20044571L (es) |
| NZ (1) | NZ535885A (es) |
| PA (1) | PA8572001A1 (es) |
| PE (1) | PE20040594A1 (es) |
| PL (1) | PL373697A1 (es) |
| PT (1) | PT1501804E (es) |
| RU (1) | RU2318812C2 (es) |
| SI (1) | SI1501804T1 (es) |
| TW (1) | TWI278451B (es) |
| UY (1) | UY27786A1 (es) |
| WO (1) | WO2003091219A1 (es) |
| ZA (1) | ZA200408281B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2558761T3 (es) * | 2003-05-19 | 2016-02-08 | Novartis Ag | Compuestos y composiciones inmunosupresores |
| JP4575920B2 (ja) * | 2003-05-19 | 2010-11-04 | アイアールエム・リミテッド・ライアビリティ・カンパニー | 免疫抑制化合物および組成物 |
| MY150088A (en) | 2003-05-19 | 2013-11-29 | Irm Llc | Immunosuppressant compounds and compositions |
| KR101186386B1 (ko) | 2003-08-29 | 2012-09-26 | 오노 야꾸힝 고교 가부시키가이샤 | Ｓ１ｐ 수용체 결합능을 갖는 화합물 및 그 의약 용도 |
| CN1874991A (zh) | 2003-08-29 | 2006-12-06 | 小野药品工业株式会社 | 能够结合s1p受体的化合物及其药物用途 |
| ATE411027T1 (de) * | 2003-10-23 | 2008-10-15 | Hoffmann La Roche | Benzazepin-derivate als mao-b-hemmer |
| AU2005250077B2 (en) | 2004-03-01 | 2011-06-09 | Idorsia Pharmaceuticals Ltd | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| KR101262400B1 (ko) | 2004-12-13 | 2013-05-08 | 오노 야꾸힝 고교 가부시키가이샤 | 아미노카르복실산 유도체 및 그 의약 용도 |
| EP1844033B1 (de) * | 2005-01-28 | 2011-07-27 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur herstellung von isochroman und derivaten davon |
| BRPI0606187A2 (pt) | 2005-02-25 | 2009-06-09 | Hoffmann La Roche | comprimidos com capacidade de dispersão da substáncia do fármaco melhorada |
| AU2006329040C1 (en) * | 2005-12-22 | 2011-12-08 | Newron Pharmaceuticals S.P.A. | 2 -Phenylethylamino derivatives as calcium and/or sodium channel modulators |
| CN101400348A (zh) * | 2006-03-15 | 2009-04-01 | 埃科特莱茵药品有限公司 | 用于提高记忆功能的四氢异喹啉衍生物 |
| EP2013209B1 (en) | 2006-04-26 | 2011-01-19 | Actelion Pharmaceuticals Ltd. | Pyrazolo-tetrahydropyridine derivatives as orexin receptor antagonists |
| KR101220182B1 (ko) * | 2009-02-25 | 2013-01-11 | 에스케이바이오팜 주식회사 | 치환된 아졸 유도체 화합물, 이를 포함하는 약제학적 조성물 및 이를 이용한 파킨슨씨 병 치료방법 |
| CN105315204B (zh) * | 2014-07-04 | 2018-02-09 | 中南大学 | 7‑氨基‑1,4‑二氢异喹啉‑3(2h)‑酮衍生物及其合成方法和用途 |
| CN105585527B (zh) * | 2015-12-17 | 2018-06-26 | 浙江工业大学 | 2-(3,4-二氢异喹啉-1(2h)-亚基)乙腈类化合物及其应用 |
| CN105461626B (zh) * | 2015-12-17 | 2018-05-08 | 浙江工业大学 | 芳环或稠杂环联3,4-二氢异喹啉类共轭结构化合物及其应用 |
| ES2961550T3 (es) * | 2017-03-27 | 2024-03-12 | Bristol Myers Squibb Co | Derivados de isoquinolina sustituidos como inmunomoduladores |
| CN114591238B (zh) * | 2022-03-25 | 2022-11-15 | 邦恩泰(山东)生物医药科技集团股份有限公司 | 一种异喹啉类药物中间体的合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6448269B1 (en) * | 1993-07-22 | 2002-09-10 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
| IL110172A (en) * | 1993-07-22 | 2001-10-31 | Lilly Co Eli | Bicycle compounds and pharmaceuticals containing them |
| US6137002A (en) * | 1993-07-22 | 2000-10-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
| US5731324A (en) * | 1993-07-22 | 1998-03-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
| US5679715A (en) | 1995-06-07 | 1997-10-21 | Harris; Richard Y. | Method for treating multiple sclerosis |
| JP3258027B2 (ja) | 1996-03-15 | 2002-02-18 | サマーセット・ファーマシューティカルズ・インコーポレイテッド | セレジリン投与による末梢ニューロパシーの予防および治療方法 |
| AU1359801A (en) | 1999-11-05 | 2001-06-06 | Vela Pharmaceuticals Inc. | Methods and compositions for treating reward deficiency syndrome |
-
2003
- 2003-04-14 RU RU2004134575/04A patent/RU2318812C2/ru not_active IP Right Cessation
- 2003-04-14 AT AT03725018T patent/ATE440821T1/de not_active IP Right Cessation
- 2003-04-14 CN CNB038093766A patent/CN1310890C/zh not_active Expired - Fee Related
- 2003-04-14 PT PT03725018T patent/PT1501804E/pt unknown
- 2003-04-14 KR KR1020047017185A patent/KR100681585B1/ko not_active IP Right Cessation
- 2003-04-14 DE DE60328978T patent/DE60328978D1/de not_active Expired - Lifetime
- 2003-04-14 EP EP03725018A patent/EP1501804B1/en not_active Expired - Lifetime
- 2003-04-14 NZ NZ535885A patent/NZ535885A/en not_active IP Right Cessation
- 2003-04-14 BR BR0309562-2A patent/BR0309562A/pt not_active IP Right Cessation
- 2003-04-14 ES ES03725018T patent/ES2329354T3/es not_active Expired - Lifetime
- 2003-04-14 MX MXPA04010537A patent/MXPA04010537A/es active IP Right Grant
- 2003-04-14 SI SI200331658T patent/SI1501804T1/sl unknown
- 2003-04-14 JP JP2003587782A patent/JP4322685B2/ja not_active Expired - Fee Related
- 2003-04-14 CA CA2483461A patent/CA2483461C/en not_active Expired - Fee Related
- 2003-04-14 AU AU2003227614A patent/AU2003227614B2/en not_active Ceased
- 2003-04-14 PL PL03373697A patent/PL373697A1/xx unknown
- 2003-04-14 WO PCT/EP2003/003845 patent/WO2003091219A1/en active Application Filing
- 2003-04-14 DK DK03725018T patent/DK1501804T3/da active
- 2003-04-16 US US10/417,378 patent/US6818774B2/en not_active Expired - Fee Related
- 2003-04-23 TW TW092109478A patent/TWI278451B/zh not_active IP Right Cessation
- 2003-04-23 PA PA20038572001A patent/PA8572001A1/es unknown
- 2003-04-24 PE PE2003000408A patent/PE20040594A1/es not_active Application Discontinuation
- 2003-04-24 AR ARP030101412A patent/AR039651A1/es unknown
- 2003-04-24 GT GT200300095A patent/GT200300095A/es unknown
- 2003-04-25 MY MYPI20031578A patent/MY133527A/en unknown
- 2003-04-28 UY UY27786A patent/UY27786A1/es not_active Application Discontinuation
-
2004
- 2004-10-12 HR HR20040952A patent/HRP20040952A2/hr not_active Application Discontinuation
- 2004-10-13 ZA ZA200408281A patent/ZA200408281B/xx unknown
- 2004-10-18 IL IL16467704A patent/IL164677A0/xx not_active IP Right Cessation
- 2004-10-22 NO NO20044571A patent/NO20044571L/no not_active Application Discontinuation
-
2006
- 2006-01-13 HK HK06100541A patent/HK1080836A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR039651A1 (es) | Derivados de isoquinolina | |
| AR029216A1 (es) | Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento | |
| AR037489A1 (es) | Quinolinas sustituidas y proceso para su preparacion | |
| ECSP034475A (es) | Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1 | |
| AR035320A1 (es) | Compuestos activadores de hppardelta, composicion farmaceutica, su uso en la preparacion de medicamentos, metodo para el tratamiento de enfermedades mediadas por hppardelta | |
| AR030533A1 (es) | Compuestos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas, composicion farmaceutica, procedimiento de tratamiento intermediario | |
| PE20070218A1 (es) | COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA | |
| CL2004000174A1 (es) | Compuestos derivados de malonamida n,n'-disustituidos; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de la enfermedad de alzheimer. | |
| AR041297A1 (es) | Derivados de 4-pirrolidino- fenil- bencil eter | |
| PE20040937A1 (es) | Derivados de piridazin-3(2h)-ona como inhibidores de fosfodiesterasa-4 (pde 4) | |
| ES2187983T3 (es) | Derivados 1,2,3,4-tetrahidronaftaleno sustituidos. | |
| PE20091621A1 (es) | Derivados de amina como moduladores de la actividad de tlr y composiciones que los contienen | |
| PA8522001A1 (es) | Pro - farmacos de derivados de 4- fenil - piridin. | |
| MX9305379A (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene. | |
| UY27503A1 (es) | Nuevos derivados de piperazina | |
| AR045161A1 (es) | Derivados de quinazolina | |
| AR032877A1 (es) | Inhibidores alquil c(1-6)-4-amino-azepan-3-onicos de proteasas, composiciones farmaceuticas que los comprenden, intermediarios utiles en la preparacion de tales compuestos, procedimiento para la sintesis de dichos inhibidores, y uso de dichos inhibidores en la fabricacion de medicamentos | |
| AR035153A1 (es) | Derivados de carboxamidas y cetonas de dihidrobenzodioxina | |
| AR040489A1 (es) | Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido, su uso para la elaboracion de medicamentos, un proceso para elaborar los compuestos y medicamentos que los contienen | |
| PA8575001A1 (es) | Fluorobenzamidas como inhibidores de maob | |
| AR040278A1 (es) | Ligandos del receptor de glucocorticoides para el tratamiento de trastornos metabolicos | |
| AR048567A1 (es) | Derivados de benzoxazinona, su preparacion y composiciones farmaceuticas. | |
| BR0315777A (pt) | Uso de derivados de piperazina como antagonistas ccr1 | |
| ATE372995T1 (de) | Benzo(b)(1,4)dioxepinderivate | |
| PA8561501A1 (es) | Lactamas como antagonistas de taquiquininas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |